Pharmacogenetics in heart failure: genomic markers of endothelial and neurohumoral function.

Congestive heart failure (Greenwich, Conn.)

Volumn 10, Issue 6, 2004, Pages 302-308

  McNamara, Dennis M ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACE PROTEIN, HUMAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE;

ALLELE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; GENETIC POLYMORPHISM; GENETICS; HUMAN; NEGRO; PHARMACOGENETICS; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HUMANS; NITRIC OXIDE; PEPTIDYL-DIPEPTIDASE A; PHARMACOGENETICS; POLYMORPHISM, GENETIC;

EID: 16644386813     PISSN: 15275299     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2004.03855.x     Document Type: Review

References (31)